 | • レポートコード：TPM-B04104 • 出版社/出版日：Transparency Market Research / 2017年12月 • レポート形態：英文、PDF、170ページ • 納品方法：Eメール • 産業分類：製薬・医療 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Global Site License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、カルグルミン酸の世界市場について調べ、カルグルミン酸の世界規模、市場動向、市場環境、形態別分析、流通経路別分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、関連企業情報などをまとめた調査レポートです。 ・序文・調査範囲・調査手法 ・エグゼクティブサマリー ・カルグルミン酸の世界市場動向 ・カルグルミン酸の世界市場環境 ・カルグルミン酸の世界市場規模 ・カルグルミン酸の世界市場規模：形態別 ・カルグルミン酸の世界市場規模：流通経路別 ・カルグルミン酸の世界市場：地域別市場規模・分析 ・カルグルミン酸の北米市場規模・予測 ・カルグルミン酸のアメリカ市場規模・予測 ・カルグルミン酸の中南米市場規模・予測 ・カルグルミン酸のヨーロッパ市場規模・予測 ・カルグルミン酸のアジア市場規模・予測 ・カルグルミン酸の日本市場規模・予測 ・カルグルミン酸の中東市場規模・予測 ・カルグルミン酸のアフリカ市場規模・予測 ・競争状況・関連企業情報 |
Transparency Market Research (TMR) has compiled a new comprehensive report on the global carglumic acid market for the forecast period 2017 to 2026. The report offers insightful forecasts on global carglumic acid market, and has examined the market in detail, providing key market dynamics inclusively. In addition to the provision of intelligence on latest trends, restraining factors, and fostering factors affecting the market expansion, the report includes analysis on data pertaining to multiple market parameters.
Report Structure
The report’s beginning chapter presents an executive summary of global market for carglumic acid. A précis of global carglumic acid market is delivered in this chapter. Additionally, important market numbers such as historical (2012-2016) & forecast (2017-2026) CAGRs have been rendered, regarding the market segments particularly. Based on sales expansion and revenues collected from carglumic acid sales globally, information about remunerative regions for growth of the carglumic acid market is delivered in the report.
A chapter titled overview proceeds after the global carglumic acid market’s executive summary, which incorporates the definition of “carglumic acid” that follows a succinct market introduction. Overview of the global carglumic acid market indicates a clear scenario of global carglumic acid market’s broad scope. The chapters subsequent to overview illuminate key dynamics impacting global demand for carglumic acid, and engulfs imperative points that include the global economy, the bottom line of enterprises, and the fiscal stimulus. The report’s following chapters comprise information on pricing analysis as well as cost structure of the carglumic acid market.
Competition Landscape
A scrupulous analysis on global carglumic acid market’s competition landscape is provided in the report, incorporating information about active industries that are contributing significantly to the market expansion. Occupancy of major market participants is tracked by the report with an intensity map. Emphasizing on profiling key market participants rigorously, this chapter offers Insights about players based on the SWOT analysis, which elucidates strengths, weaknesses, opportunities, & threats affecting that specific market participant. In addition, information on key developments, key financials, company overview, and product overview pertaining to market players is also comprised in this chapter of the report. The competition landscape is a crucial chapter for this report’s readers, as it gives all necessary knowledge appertaining to companies, coupled with the novel strategies employed by them to stay at global carglumic acid market’s front edge.
Research Methodology
A research methodology, which is proven and tested, has been used by TMR’s analysts while developing the report on carglumic acid market, which has aided them in providing precise & accurate insights on the carglumic acid market. Research methodology adopted entirely depends on the primary and the secondary researches, for further gaining necessary information about global carglumic acid market. This information attained is then validated by the analysts several times, just to ensure its authenticity as well as for making it an authoritative reference for report readers.
レポート目次Chapter 1 Global Outlook
1.1 Global Healthcare Sector Outlook
Chapter 2 Global Carglumic Acid Market – Executive Summary
Chapter 3 Global Carglumic Acid Market Overview
3.1 Introduction
3.1.1 Global Carglumic Acid Market Taxonomy
3.1.2 Global Carglumic Acid Market Definition
3.2 Global Carglumic Acid Market Size (US$ Mn) and Forecast, 2012-2026
3.2.1 Global Carglumic Acid Market Y-o-Y Growth
3.3 Global Carglumic Acid Market Dynamics
3.4 Supply Chain
3.5 Cost Structure
3.6 Pricing Analysis
3.7 Reimbursement Scenario
3.8 Carglumic Acid Indication and Usage
3.9 Dosage and Administration of Carglumic Acid
3.10 Use of Carglumic Acid in Specific Population
3.11 Key Regulations
3.11.1 North America Key Regulations
3.11.2 Latin America Key Regulations
3.11.3 Europe – Key Regulations
3.11.4 APEJ – Key Regulations
3.11.5 MEA – Key Regulations
3.12 PEST Analysis
3.13 Drug Pipeline Assessment
3.14 Clinical Trials on Carglumic Study
3.15 List of Distributors
Chapter 4 Global Carglumic Acid Market Analysis and Forecast 2012-2026
4.1 Global Carglumic Acid Market Size and Forecast By Delivery Format, 2012-2026
4.1.1 Tablet, orally disintegrating Market Size and Forecast, 2012-2026
4.1.1.1 Revenue (US$ Mn) Comparison, By Region
4.1.1.2 Market Share Comparison, By Region
4.1.1.3 Y-o-Y growth Comparison, By Region
4.1.2 Tablet, for suspension Market Size and Forecast, 2012-2026
4.1.2.1 Revenue (US$ Mn) Comparison, By Region
4.1.2.2 Market Share Comparison, By Region
4.1.2.3 Y-o-Y growth Comparison, By Region
4.2 Global Carglumic Acid Market Size and Forecast By Distribution Channel, 2012-2026
4.2.1 Hospital Pharmacies Market Size and Forecast, 2012-2026
4.2.1.1 Revenue (US$ Mn) Comparison, By Region
4.2.1.2 Market Share Comparison, By Region
4.2.1.3 Y-o-Y growth Comparison, By Region
4.2.2 Retail Pharmacies Market Size and Forecast, 2012-2026
4.2.2.1 Revenue (US$ Mn) Comparison, By Region
4.2.2.2 Market Share Comparison, By Region
4.2.2.3 Y-o-Y growth Comparison, By Region
4.2.3 E-Commerce Market Size and Forecast, 2012-2026
4.2.3.1 Revenue (US$ Mn) Comparison, By Region
4.2.3.2 Market Share Comparison, By Region
4.2.3.3 Y-o-Y growth Comparison, By Region
Chapter 5 North America Carglumic Acid Market Size and Forecast, 2012-2026
5.1 North America Market Outlook
5.1.1 Political Outlook
5.1.2 Economic Outlook
5.1.3 Business Environment Outlook
5.1.4 North America Healthcare Sector Outlook: Will the Obama Care Senate Repeal Bill Thrash Federal Medicaid Healthcare Funding?
5.1.5 North America Carglumic Acid Market Overlook:
5.2 Revenue (US$ Mn) Comparison, By Country
5.3 Revenue (US$ Mn) Comparison, By Delivery Format
5.4 Revenue (US$ Mn) Comparison, By Distribution Channel
Chapter 6 Latin America Carglumic Acid Market Size and Forecast, 2012-2026
6.1 Latin America Market Outlook
6.1.1 Political Outlook
6.1.2 Economic Outlook
6.1.3 Business Environment Outlook
6.1.4 Latin America Healthcare Sector Outlook: Growing Public-Private Partnerships are augmenting the Provision of Basic Healthcare Services
6.1.5 Latin America Carglumic Acid Market Outlook:
6.2 Revenue (US$ Mn) Comparison, By Country
6.3 Revenue (US$ Mn) Comparison, By Delivery Format
6.4 Revenue (US$ Mn) Comparison, By Distribution Channel
Chapter 7 Europe Carglumic Acid Market Size and Forecast, 2012-2026
7.1 Europe Market Outlook
7.1.1 Political Outlook
7.1.2 Economic Outlook
7.1.3 Business Environment Outlook
7.1.4 Europe Healthcare Sector Outlook
7.1.5 Europe Carglumic Acid Market Outlook
7.2 Revenue (US$ Mn) Comparison, By Country
7.3 Revenue (US$ Mn) Comparison, By Delivery Format
7.4 Revenue (US$ Mn) Comparison, By Distribution Channel
Chapter 8 Japan Carglumic Acid Market Size and Forecast, 2012-2026
8.1 Japan Market Outlook
8.1.1 Political Outlook
8.1.2 Economic Outlook
8.1.3 Business Environment Outlook
8.1.4 Japan Healthcare Sector Outlook: Generics Will Continue to Create New Opportunities, While the Overall Environment Remains Conducive for Innovation in Clinical Trials and Biotech
8.1.5 Japan Carglumic Acid Market Outlook:
8.2 Revenue (US$ Mn) Comparison, By Country
8.3 Revenue (US$ Mn) Comparison, By Delivery Format
8.4 Revenue (US$ Mn) Comparison, By Distribution Channel
Chapter 9 APEJ Carglumic Acid Market Size and Forecast, 2012-2026
9.1 APEJ Market Outlook
9.1.1 Political Outlook
9.1.2 Economic Outlook
9.1.3 Business Environment Outlook
9.1.4 Asia Pacific Excluding Japan (APEJ) Healthcare Sector Outlook9.1.5 Asia Pacific Excluding Japan (APEJ) Carglumic Acid Market Outlook:
9.2 Revenue (US$ Mn) Comparison, By Country
9.3 Revenue (US$ Mn) Comparison, By Delivery Format
9.4 Revenue (US$ Mn) Comparison, By Distribution Channel
Chapter 10 MEA Carglumic Acid Market Size and Forecast, 2012-2026
10.1 MEA Market Outlook
10.1.1 Political Outlook
10.1.2 Economic Outlook
10.1.3 Business Environment Outlook
10.1.4 Middle East & Africa (MEA) Healthcare Sector Outlook
10.1.5 Middle East & Africa (MEA) Carglumic Acid Market Outlook
10.2 Revenue (US$ Mn) Comparison, By Country
10.3 Revenue (US$ Mn) Comparison, By Delivery Format
10.4 Revenue (US$ Mn) Comparison, By Distribution Channel
Chapter 11 Global Carglumic Acid Market Company Profiles
11.1 Recordati S.p.A.
11.1.1 Company Overview
11.1.2 Product Overview
11.1.3 Key Financials
11.1.4 Key Developments
11.1.5 SWOT Analysis
11.2 Civentichem, LLC
11.2.1 Company Overview
11.2.2 Product Overview
11.3 Dipharma Francis S.r.l.
11.3.1 Company Overview
11.3.2 Product Overview
11.4 Key Takeaways of Carglumic Acid Market
Chapter 12 TMR Research Methodology
Chapter 13 Disclaimer and Contact information
List of TablesTABLE 1 Global Carglumic Acid Market Value (US$ Mn), 2012-2017
TABLE 2 Global Carglumic Acid Market Value (US$ Mn), 2018-2026
TABLE 3 Global Carglumic Acid Market Value (US$ Mn) and Y-o-Y, 2017-2026
TABLE 4 Global Tablet, orally disintegrating Segment Value (US$ Mn), By Region 2012-2017
TABLE 5 Global Tablet, orally disintegrating Segment Value (US$ Mn), By Region 2018-2026
TABLE 6 Global Tablet, orally disintegrating Segment Market Share, By Region 2012-2017
TABLE 7 Global Tablet, orally disintegrating Segment Market Share, By Region 2018-2026
TABLE 8 Global Tablet, orally disintegrating Segment Y-o-Y, By Region 2017-2026
TABLE 9 Global Tablet, for suspension Segment Value (US$ Mn), By Region 2012-2017
TABLE 10 Global Tablet, for suspension Segment Value (US$ Mn), By Region 2018-2026
TABLE 11 Global Tablet, for suspension Segment Market Share, By Region 2012-2017
TABLE 12 Global Tablet, for suspension Segment Market Share, By Region 2018-2026
TABLE 13 Global Tablet, for suspension Segment Y-o-Y, By Region 2017-2026
TABLE 14 Global Hospital Pharmacies Segment Value (US$ Mn), By Region 2012-2017
TABLE 15 Global Hospital Pharmacies Segment Value (US$ Mn), By Region 2018-2026
TABLE 16 Global Hospital Pharmacies Segment Market Share, By Region 2012-2017
TABLE 17 Global Hospital Pharmacies Segment Market Share, By Region 2018-2026
TABLE 18 Global Hospital Pharmacies Segment Y-o-Y, By Region 2017-2026
TABLE 19 Global Retail Pharmacies Segment Value (US$ Mn), By Region 2012-2017
TABLE 20 Global Retail Pharmacies Segment Value (US$ Mn), By Region 2018-2026
TABLE 21 Global Retail Pharmacies Segment Market Share, By Region 2012-2017
TABLE 22 Global Retail Pharmacies Segment Market Share, By Region 2018-2026
TABLE 23 Global Retail Pharmacies Segment Y-o-Y, By Region 2017-2026
TABLE 24 Global E-Commerce Segment Value (US$ Mn), By Region 2012-2017
TABLE 25 Global E-Commerce Segment Value (US$ Mn), By Region 2018-2026
TABLE 26 Global E-Commerce Segment Market Share, By Region 2012-2017
TABLE 27 Global E-Commerce Segment Market Share, By Region 2018-2026
TABLE 28 Global E-Commerce Segment Y-o-Y, By Region 2017-2026
TABLE 29 North America Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 30 North America Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 31 North America Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 32 North America Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 33 North America Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 34 North America Carglumic Acid Market Value (US$ Mn), By Country 2012-2017
TABLE 35 North America Carglumic Acid Market Value (US$ Mn), By Country 2018-2026
TABLE 36 North America Carglumic Acid Market Value (US$ Mn), By Delivery Format 2012-2017
TABLE 37 North America Carglumic Acid Market Value (US$ Mn), By Delivery Format 2018-2026
TABLE 38 North America Carglumic Acid Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 39 North America Carglumic Acid Market Value (US$ Mn), By Distribution Channel 2018-2026
TABLE 40 Latin America Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 41 Latin America Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 42 Latin America Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 43 Latin America Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 44 Latin America Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 45 Latin America Carglumic Acid Market Value (US$ Mn), By Country 2012-2017
TABLE 46 Latin America Carglumic Acid Market Value (US$ Mn), By Country 2018-2026
TABLE 47 Latin America Carglumic Acid Market Value (US$ Mn), By Delivery Format 2012-2017
TABLE 48 Latin America Carglumic Acid Market Value (US$ Mn), By Delivery Format 2018-2026
TABLE 49 Latin America Carglumic Acid Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 50 Latin America Carglumic Acid Market Value (US$ Mn), By Distribution Channel 2018-2026
TABLE 51 Europe Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 52 Europe Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 53 Europe Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 54 Europe Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 55 Europe Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 56 Europe Carglumic Acid Market Value (US$ Mn), By Country 2012-2017
TABLE 57 Europe Carglumic Acid Market Value (US$ Mn), By Country 2018-2026
TABLE 58 Europe Carglumic Acid Market Value (US$ Mn), By Delivery Format 2012-2017
TABLE 59 Europe Carglumic Acid Market Value (US$ Mn), By Delivery Format 2018-2026
TABLE 60 Europe Carglumic Acid Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 61 Europe Carglumic Acid Market Value (US$ Mn), By Distribution Channel 2018-2026
TABLE 62 Japan Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 63 Japan Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 64 Japan Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 65 Japan Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 66 Japan Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 67 Japan Carglumic Acid Market Value (US$ Mn), By Country 2012-2017
TABLE 68 Japan Carglumic Acid Market Value (US$ Mn), By Country 2018-2026
TABLE 69 Japan Carglumic Acid Market Value (US$ Mn), By Delivery Format 2012-2017
TABLE 70 Japan Carglumic Acid Market Value (US$ Mn), By Delivery Format 2018-2026
TABLE 71 Japan Carglumic Acid Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 72 Japan Carglumic Acid Market Value (US$ Mn), By Distribution Channel 2018-2026
TABLE 73 APEJ Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 74 APEJ Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 75 APEJ Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 76 APEJ Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 77 APEJ Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 78 APEJ Carglumic Acid Market Value (US$ Mn), By Country 2012-2017
TABLE 79 APEJ Carglumic Acid Market Value (US$ Mn), By Country 2018-2026
TABLE 80 APEJ Carglumic Acid Market Value (US$ Mn), By Delivery Format 2012-2017
TABLE 81 APEJ Carglumic Acid Market Value (US$ Mn), By Delivery Format 2018-2026
TABLE 82 APEJ Carglumic Acid Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 83 APEJ Carglumic Acid Market Value (US$ Mn), By Distribution Channel 2018-2026
TABLE 84 MEA Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 85 MEA Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 86 MEA Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 87 MEA Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 88 MEA Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 89 MEA Carglumic Acid Market Value (US$ Mn), By Country 2012-2017
TABLE 90 MEA Carglumic Acid Market Value (US$ Mn), By Country 2018-2026
TABLE 91 MEA Carglumic Acid Market Value (US$ Mn), By Delivery Format 2012-2017
TABLE 92 MEA Carglumic Acid Market Value (US$ Mn), By Delivery Format 2018-2026
TABLE 93 MEA Carglumic Acid Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 94 MEA Carglumic Acid Market Value (US$ Mn), By Distribution Channel 2018-2026